Europeiska unionen -
norska -
EMA (European Medicines Agency)
oxbryta
pfizer europe ma eeig - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.
Europeiska unionen -
norska -
EMA (European Medicines Agency)
enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunsuppressive - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).
Europeiska unionen -
norska -
EMA (European Medicines Agency)
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemiske preparater - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
Norge -
norska -
Statens legemiddelverk
copemyl 20 mg/ ml
orifarm as - glatirameracetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 20 mg/ ml